Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Amanda Mocroft
  • Schlomo Staszewski
  • Rainer Weber
  • José Gatell
  • Jurgen Rockstroh
  • Jacek Gasiorowski
  • George Panos
  • Antonella d'Arminio Monforte
  • Aza Rakhmanova
  • Andrew N Phillips
  • Lundgren, Jens
  • Eurosida Study Group
It is unknown whether the increased risk of toxicities in antiretroviral-naive HIV-infected patients initiating nevirapine-based (NVPc) combination antiretroviral therapy (cART) with high CD4+ T-cell counts is also observed when NVPc is initiated in cARTexperienced patients.
OriginalsprogEngelsk
TidsskriftAntiviral Therapy
Vol/bind12
Udgave nummer3
Sider (fra-til)325-33
Antal sider9
ISSN1359-6535
StatusUdgivet - 2007

ID: 37724990